Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAD-alum + Vitamin D in LADA
NCT04262479Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Mar 2020
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 2
01
Overview
A Phase 2 trial of Diamyd in latent autoimmune diabetes in adults (LADA), sponsored by Norwegian University of Science and Technology. Started Mar 2020; status: completed.
02
Drugs
Diamyd
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT04262479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04262479.